• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Regeneron Pharmaceuticals, Inc. (REGN)

    -NasdaqGS
    413.84 Down 6.03(1.44%) Feb 27, 4:00PM EST
    |After Hours : 414.00 Up 0.16 (0.04%) Feb 27, 7:13PM EST
    Add to Portfolio
    Prev Close:419.87
    Open:421.04
    Bid:412.00 x 100
    Ask:N/A
    1y Target Est:444.45
    Beta:0.93
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:411.04 - 421.07
    52wk Range:269.50 - 437.64
    Volume:811,008
    Avg Vol (3m):827,513
    Market Cap:42.16B
    P/E (ttm):134.80
    EPS (ttm):3.07
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    REGNDown 1.44%42.16B
    AMGNDown 0.79%119.69B
    NVSDown 0.58%245.62B
    RHHBYUp 0.80%N/A

    Key Statistics

    Forward P/E (1 yr):33.59
    P/S (ttm):15.17
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :10.74
    Quarterly EPS Est (Mar-15) :2.70
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):2.04

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback